Sexton Riley LLP represented Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in its June 2022 research collaboration agreement with Serotiny to optimize CAR designs for cellular therapy. https://www.businesswire.com/news/home/20220606005160/en/Serotiny-Announces-a-Research-Collaboration-With-Janssen-to-Optimize-Designs-for-Chimeric-Antigen-Receptors-Signaling-Domains
top of page
bottom of page